Evidence map›Paper›PMID 23185404›Full record

ArticlePloS one2012

Toxic element contamination of natural health products and pharmaceutical preparations.

Stephen J Genuis, Gerry Schwalfenberg, Anna-Kristen J Siy, Ilya Rodushkin

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Bioaccessibility, exposure and risk assessment of potentially toxic elements and essential micronutrients in ayurvedic, traditional Chinese and Ghanaian medicines.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  5. Article
  6. Update on Toxic Neuropathies.Current treatment options in neurology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Mercury in natural health products as a cause of membranous nephropathy.Proceedings (Baylor University. Medical Center) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stephen J GenuisFaculty of Medicine, University of Alberta, Edmonton, Alberta, Canada. sgenuis@ualberta.ca
Gerry Schwalfenberg
Anna-Kristen J Siy
Ilya Rodushkin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConcern has recently emerged regarding the safety of natural health products (NHPs)-therapies that are increasingly recommended by various health providers, including conventional physicians. Recognizing that most individuals in the Western world now consume vitamins and many take herbal agents, this study endeavored to determine levels of toxic element contamination within a range of NHPs.

methodsToxic element testing was performed on 121 NHPs (including Ayurvedic, traditional Chinese, and various marine-source products) as well as 49 routinely prescribed pharmaceutical preparations. Testing was also performed on several batches of one prenatal supplement, with multiple samples tested within each batch. Results were compared to existing toxicant regulatory limits.

resultsToxic element contamination was found in many supplements and pharmaceuticals; levels exceeding established limits were only found in a small percentage of the NHPs tested and none of the drugs tested. Some NHPs demonstrated contamination levels above preferred daily endpoints for mercury, cadmium, lead, arsenic or aluminum. NHPs manufactured in China generally had higher levels of mercury and aluminum.

conclusionsExposure to toxic elements is occurring regularly as a result of some contaminated NHPs. Best practices for quality control-developed and implemented by the NHP industry with government oversight-is recommended to guard the safety of unsuspecting consumers.

Indexed as

Drug ContaminationPatient SafetyAlbertaArsenicBiological ProductsCadmiumComplementary TherapiesDietary SupplementsHumansLeadMedicine, Chinese TraditionalMercuryMetalsOntarioVitaminsArsenicBiological ProductsCadmiumLeadMercuryMetalsVitamins

Identifiers

PMID23185404
PMCPMC3504157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.